Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence Study of Germline and/or Somatic BRCA1/2 Mutation in Korean Patients With High-Grade Serous and/or Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02963688 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02963688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02963688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence Study of Germline and/or Somatic BRCA1/2 Mutation in Korean Patients With High-Grade Serous and/or Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2015
Enrollment
298 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

to investigate the prevalence of brca 1/2 mutation among ovarian cancer